CLOVER HEALTH INVESTMENTS, CORP. DE (CLOV)
2025-06-30 | 2024-09-30 | 2024-06-30 | ||
|---|---|---|---|---|
| Total revenues | 477,620 | 330,986 | 356,260 | |
| Restructuring costs | - | -538 | 473 | |
| Net medical claims incurred | 377,992 | 249,774 | 248,347 | |
| Salaries and benefits | 61,309 | 54,995 | 55,499 | |
| General and administrative expenses | 48,484 | 35,201 | 44,424 | |
| Depreciation and amortization | 394 | 339 | 330 | |
| Total operating expenses | 488,179 | 339,771 | 349,073 | |
| (loss) income from continuing operations | -10,559 | -8,785 | 7,187 | |
| Loss on investment | - | - | - | |
| Change in fair value of warrants | 19 | - | 17 | |
| Net (loss) income from continuing operations | -10,578 | -8,785 | 7,170 | |
| Net income from discontinued operations | - | -370 | 238 | |
| Net (loss) income | -10,578 | -9,155 | 7,408 | |
| Net unrealized gain on available-for-sale investments | 251 | 3,111 | 301 | |
| Comprehensive (loss) income | -10,327 | -6,044 | 7,709 | |
| Basic weighted average number of class a and class b common shares and common share equivalents outstanding (in shares) | 509,043,210 | 490,180,103 | 487,483,087 | |
| Diluted weighted average number of class a and class b common shares and common share equivalents outstanding (in shares) | 509,043,210 | 490,180,103 | 495,179,955 | |